content: <PAGE>
   
                       SECURITIES AND EXCHANGE COMMISSION
  
                            Washington, D. C.  20549
  
                                    FORM 8-K
  
                                 CURRENT REPORT
  
                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934
  
      Date of Report (Date of earliest event reported):  September 23, 1998
  
                                  IXYS CORPORATION
               (Exact name of registrant as specified in its charter)
  
           Delaware                   0-26124                      770140882-5
  (State or other jurisdiction   (Commission File No.)           (IRS Employer 
       of incorporation)                                      (Identification No.)
                                       
                                3540 Bassett Street
                              Santa Clara, CA  95054
               (Address of principal executive offices and zip code)
  
        Registrant's telephone number, including area code:  (408) 982-0700
  
                             PARADIGM TECHNOLOGY, INC.
                                 694 Tasman Drive
                                Milpitas, CA 95035
           (Former name or former address, if changed since last report)
  <PAGE>
   
  ITEM 1.  CHANGE IN CONTROL OF REGISTRANT
  
  This Current Report on Form 8-K (the "Report") is filed by IXYS Corporation, a
  Delaware corporation formerly named Paradigm Technology, Inc. (the 
  "Registrant").
  
  This Report contains forward looking statements that involve risks and
  uncertainties, including risks that the integration of the operations,
  technologies, products and employees of IXYS USA, Inc., a Delaware corporation
  formerly named IXYS Corporation ("IXYS USA"), and the Registrant might not occur
  as anticipated; that the synergies expected to result from the merger described
  below might not occur as anticipated; that management's attention might be
  diverted from day-to-day business activities; and that greater than normal
  employee turnover might occur. In addition, there are normal risks and
  uncertainties associated with the Registrant's business, including risks
  relating to the timing and magnitude of product sales, timely development,
  acceptance and pricing of new products and technological advances and the impact
  of competitive conditions. Actual results and developments may differ materially
  from those described in this Report. For more information about the Registrant
  and risks relating to investing in the Registrant, refer to the Registrant's
  most recent reports on Form 10-K and Form 10-Q, and to Amendment No. 2 to the
  Form S-4 Registration Statement relating to the merger described below, as filed
  by the Registrant with the United States Securities and Exchange Commission (the
  "Commission").
  
  On September 23, 1998, Paradigm Enterprises, Inc. ("Merger Sub"), which was a
  wholly-owned subsidiary of the Registrant, was merged with and into IXYS USA
  (the "Merger"), pursuant to an Agreement and Plan of Merger and Reorganization
  (the "Agreement") dated as of March 9, 1998, as amended, among IXYS USA, Merger
  Sub and the Registrant.
  
  In connection with the Merger, Michael Gullett and George Collins resigned as
  directors of the Registrant, and Nathan Zommer, Arnold Agbayani and Rolf Karg
  became directors of the Registrant.  James Kochman was the only individual to
  remain a director of the Registrant before and after the Merger.  Dr. Karg is
  affiliated with Asea Brown Boveri AG ("ABB").  Upon the Merger, Dr. Zommer
  became the President and Chief Executive Officer of the Registrant and Mr.
  Agbayani became the Vice President of Finance and Administration, Chief
  Financial Officer and Secretary of the Registrant.
  
  Pursuant to the Merger, Dr. Zommer acquired beneficial ownership of
  approximately 3,356,188 shares of Common Stock of the Registrant, representing
  approximately 27.9% of the outstanding Common Stock of the Registrant, and ABB
  and entities affiliated with ABB acquired approximately 5,452,419 shares of
  Common Stock of the Registrant, representing approximately 45.5% of the
  outstanding Common Stock of the Registrant.  (The foregoing percentages were
  calculated in accordance with Rule 13d-3 promulgated under the Securities
  Exchange Act.)
  
  Dr. Zommer acquired shares of Common Stock of a California corporation
  predecessor to IXYS USA in exchange for a promissory note due and payable
  December 31, 1999, bearing interest at the rate of 5.79% per annum and in the
  original amount of $707,238.83 and such shares were pledged to the predecessor
  California corporation as security for such note. Such shares have successively
  been converted into shares of Common Stock of IXYS USA and
  
                                         2.
  <PAGE>
   
  into shares of Common Stock of the Registrant. IXYS USA holds such promissory
  note and is the pledgee under the related pledge agreement.
  
  ITEM 2.   ACQUISITION OR DISPOSITION OF ASSETS.
  
  The Merger became effective at the time of the filing of a Certificate of Merger
  with the Delaware Secretary of State on September 23, 1998 (the "Effective
  Time").  At the Effective Time: (i) Merger Sub ceased to exist; (ii) IXYS USA,
  as the surviving corporation in the Merger, became a wholly-owned subsidiary of
  the Registrant; and (iii) subject to the provisions of the Agreement relating to
  the payment of cash in lieu of fractional shares, each share of IXYS USA Common
  Stock, par value $0.001 per share ("IXYS Common Stock"), and each share of IXYS
  Preferred Stock, par value $0.001 per share, outstanding immediately prior to
  the Effective Time (except for any such shares held by the Registrant as
  treasury stock and any such shares held by IXYS USA or any subsidiary of IXYS
  USA or the Registrant, which shares, if any, were canceled) was converted into
  the right to receive .057842 of a share of Common Stock, $0.01 par value per
  share, of the Registrant ("Registrant Common Stock"). Following the Merger, the
  Registrant changed its name to IXYS Corporation.
  
  In addition, pursuant to the Agreement, at the Effective Time, all rights with
  respect to IXYS Common Stock under IXYS USA stock options then outstanding, were
  converted into and became rights with respect to Registrant Common Stock, and
  the Registrant assumed each such outstanding IXYS USA stock option in accordance
  with the terms of the stock option plan under which it was issued and the stock
  option agreement by which it is evidenced. By virtue of the assumption by the
  Registrant of such IXYS USA stock options, from and after the Effective Time:
  (i) each IXYS USA stock option assumed by the Registrant may be exercised solely
  for Registrant Common Stock; (ii) the number of shares of Registrant Common
  Stock subject to each such IXYS USA stock option is equal to the number of
  shares of IXYS Common Stock subject to such IXYS USA stock option immediately
  prior to the Effective Time multiplied by .057842 (the exchange ratio in the
  Merger), rounded down to the nearest whole share (with cash, less the applicable
  exercise price, being payable for any fraction of a share); and (iii) the per
  share exercise price under each such Registrant stock option was adjusted by
  dividing the per share exercise price under such Registrant stock option by
   .057842 and rounding up to the nearest cent.
  
  The former stockholders of IXYS USA are receiving approximately 11,513,821
  shares of Registrant Common Stock pursuant to the Merger. In addition,
  approximately 274,914 shares of Registrant Common Stock may be issued in
  connection with the exercise of the IXYS USA stock options assumed by the
  Registrant.
  
  The Merger is intended to be a tax-free reorganization under the Internal
  Revenue Code of 1986, as amended, and is expected to be accounted for as a
  purchase.  
  
  Prior to the Merger, all outstanding shares of Preferred Stock of the Registrant
  were converted into Common Stock of the Registrant, and a reverse stock split of
  the Common Stock of the Registrant, pursuant to which each 15 shares were
  combined into one share, occurred.  Following such conversion and reverse stock
  split, and after giving effect to the Merger, as of September 
  
                                         3.
  <PAGE>
   
  30, 1998, there were approximately 11,955,670 shares of Common Stock of
  Registrant outstanding, options to acquire approximately 281,773 shares of
  Common Stock of Registrant outstanding and warrants to acquire approximately
  198,515 shares of Common Stock of Registrant outstanding. On such date, the
  weighted average exercise price per share of such options was approximately
  $5.94, the weighted average exercise price per share of the 195,881 warrants
  assumed under the Merger was approximately $1.42, and the weighted average
  exercise price per share of the 2,634 warrants which the Registrant had
  outstanding prior to the Merger was approximately $372.00.
  
  IXYS USA designs, develops and markets a broad spectrum of power semiconductors
  used primarily in controlling energy in motor drives, power conversion
  (including uninterruptible power supplies and switch mode power supplies) and
  medical devices.  IXYS USA's power semiconductors convert electricity at
  relatively high voltage and current levels to create efficient power as required
  by a specific application.  IXYS USA's target market includes segments of the
  power semiconductor market that require medium to high power semiconductors,
  with a particular emphasis on "higher power" semiconductors, which are
  semiconductors capable of processing greater than 500 watts of power.  The
  Registrant intends to continue to use the assets of IXYS USA for the purposes
  for which such assets were used prior to the Merger.
  
  See Item 1 for additional information.
  
  ITEM 7.  FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
  
          (a) Financial Statements of the Business Acquired
  
          The audited consolidated financial statements of IXYS Corporation as of
          March 31, 1997 and 1998 and for the three years in the period ended
          March 31, 1998 were included as part of the Registration Statement on
          Form S-4 (No. 33-57003) filed by the registrant with the Commission on
          June 6, 1998, and incorporated by reference herein. The unaudited
          condensed consolidated financial statements of IXYS Corporation as of
          June 30, 1998 and for the three month periods ended June 30, 1997 and
          1998 are included as Exhibit 99.1.
  
          (b) Pro Forma Financial Information
  
          The required pro forma financial information with respect to the
          acquired business referred to in Item 2 of this Report are included as
          Exhibit 99.1.
  
          (c) Exhibits
  
  
  EXHIBIT
    No.            DESCRIPTION
  -------          -----------
  
  2.1              Agreement and Plan of Merger and Reorganization dated as of
                   March 9, 1998, as amended, among IXYS, Merger Sub and
                   Paradigm./(1)/
  
                                         4.
  <PAGE>
   
  23.1             Consent of PricewaterhouseCoopers LLP, independent
                   accountants.
  
  99.1             Financial Statements.
  
  ____________________________
  
  /(1)/ Filed as an Annex to the Joint Proxy Statement/Prospectus forming part of
        the Registration Statement on Form S-4 (No. 333-57003) filed by the
        Registrant with the Commission on June 6, 1998, and incorporated by
        reference herein.
  
  
  Item 8.  Change in Fiscal Year.
  
  In connection with the Merger on September 23, 1998, the Registrant's fiscal
  year end will become March 31 of each calendar year. Because the transaction
  constituted a reverse acquisition under generally accepted accounting
  principles, no transition report will be filed with the Commission.
  
                                         5.
  <PAGE>
   
                                     SIGNATURES
  
  Pursuant to the requirements of the Securities Exchange Act of 1934, as amended,
  the registrant has duly caused this Report to be signed on its behalf by the
  undersigned hereunto duly authorized.
  
                                           IXYS CORPORATION
  
  
  Dated:  October 8, 1998                 By: /s/ Arnold P. Agbayani 
                                              ---------------------------------
                                              Arnold P. Agbayani
                                              Vice President of Finance and
                                              Administration and Chief
                                              Financial Officer
   
  
                                         6.
  <PAGE>
   
                                   Exhibit Index
  
      EXHIBIT
        NO.        DESCRIPTION
      -------      -----------
  
      2.1          Agreement and Plan of Merger and Reorganization dated as of
                   March 9, 1998, as amended, among IXYS, Merger Sub and
                   Paradigm./(1)/
  
      23.1         Consent of PricewaterhouseCoopers LLP, independent
                   accountants.
  
      99.1         Financial Statements.
  
  ____________________________
  
  /(1)/ Filed as an Annex to the Joint Proxy Statement/Prospectus forming part of
        the Registration Statement on Form S-4 (No. 333-57003) filed by Paradigm
        Technology, Inc. with the Commission on June 6, 1998, and incorporated by
        reference herein.
metadata_documents: [{"type": "8-K", "sequence": "1", "description": "FORM 8-K", "secsgml_size_bytes": 13297}]
metadata_filer: {"company-data": {"conformed-name": "PARADIGM TECHNOLOGY INC /DE/", "cik": "0000945699", "assigned-sic": "3674", "irs-number": "770140882", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-26124", "film-number": "98722736"}, "business-address": {"street1": "694 TASMAN DR", "city": "MILPITAS", "state": "CA", "zip": "95035", "phone": "4089540500"}, "mail-address": {"street1": "PARADIGN TECHNOLOGY INC", "street2": "694 TASMAN DRIVE", "city": "MILPITAS", "state": "CA", "zip": "95035"}}
text: SECURITIES AND EXCHANGE COMMISSION
  
                            Washington, D. C.  20549
  
                                    FORM 8-K
  
                                 CURRENT REPORT
  
                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934
  
      Date of Report (Date of earliest event reported):  September 23, 1998
  
                                  IXYS CORPORATION
               (Exact name of registrant as specified in its charter)
  
           Delaware                   0-26124                      770140882-5
  (State or other jurisdiction   (Commission File No.)           (IRS Employer 
       of incorporation)                                      (Identification No.)
                                       
                                3540 Bassett Street
                              Santa Clara, CA  95054
               (Address of principal executive offices and zip code)
  
        Registrant's telephone number, including area code:  (408) 982-0700
  
                             PARADIGM TECHNOLOGY, INC.
                                 694 Tasman Drive
                                Milpitas, CA 95035
           (Former name or former address, if changed since last report)
  ITEM 1.  CHANGE IN CONTROL OF REGISTRANT
  
  This Current Report on Form 8-K (the "Report") is filed by IXYS Corporation, a
  Delaware corporation formerly named Paradigm Technology, Inc. (the 
  "Registrant").
  
  This Report contains forward looking statements that involve risks and
  uncertainties, including risks that the integration of the operations,
  technologies, products and employees of IXYS USA, Inc., a Delaware corporation
  formerly named IXYS Corporation ("IXYS USA"), and the Registrant might not occur
  as anticipated; that the synergies expected to result from the merger described
  below might not occur as anticipated; that management's attention might be
  diverted from day-to-day business activities; and that greater than normal
  employee turnover might occur. In addition, there are normal risks and
  uncertainties associated with the Registrant's business, including risks
  relating to the timing and magnitude of product sales, timely development,
  acceptance and pricing of new products and technological advances and the impact
  of competitive conditions. Actual results and developments may differ materially
  from those described in this Report. For more information about the Registrant
  and risks relating to investing in the Registrant, refer to the Registrant's
  most recent reports on Form 10-K and Form 10-Q, and to Amendment No. 2 to the
  Form S-4 Registration Statement relating to the merger described below, as filed
  by the Registrant with the United States Securities and Exchange Commission (the
  "Commission").
  
  On September 23, 1998, Paradigm Enterprises, Inc. ("Merger Sub"), which was a
  wholly-owned subsidiary of the Registrant, was merged with and into IXYS USA
  (the "Merger"), pursuant to an Agreement and Plan of Merger and Reorganization
  (the "Agreement") dated as of March 9, 1998, as amended, among IXYS USA, Merger
  Sub and the Registrant.
  
  In connection with the Merger, Michael Gullett and George Collins resigned as
  directors of the Registrant, and Nathan Zommer, Arnold Agbayani and Rolf Karg
  became directors of the Registrant.  James Kochman was the only individual to
  remain a director of the Registrant before and after the Merger.  Dr. Karg is
  affiliated with Asea Brown Boveri AG ("ABB").  Upon the Merger, Dr. Zommer
  became the President and Chief Executive Officer of the Registrant and Mr.
  Agbayani became the Vice President of Finance and Administration, Chief
  Financial Officer and Secretary of the Registrant.
  
  Pursuant to the Merger, Dr. Zommer acquired beneficial ownership of
  approximately 3,356,188 shares of Common Stock of the Registrant, representing
  approximately 27.9% of the outstanding Common Stock of the Registrant, and ABB
  and entities affiliated with ABB acquired approximately 5,452,419 shares of
  Common Stock of the Registrant, representing approximately 45.5% of the
  outstanding Common Stock of the Registrant.  (The foregoing percentages were
  calculated in accordance with Rule 13d-3 promulgated under the Securities
  Exchange Act.)
  
  Dr. Zommer acquired shares of Common Stock of a California corporation
  predecessor to IXYS USA in exchange for a promissory note due and payable
  December 31, 1999, bearing interest at the rate of 5.79% per annum and in the
  original amount of $707,238.83 and such shares were pledged to the predecessor
  California corporation as security for such note. Such shares have successively
  been converted into shares of Common Stock of IXYS USA and
  
                                         2.
  into shares of Common Stock of the Registrant. IXYS USA holds such promissory
  note and is the pledgee under the related pledge agreement.
  
  ITEM 2.   ACQUISITION OR DISPOSITION OF ASSETS.
  
  The Merger became effective at the time of the filing of a Certificate of Merger
  with the Delaware Secretary of State on September 23, 1998 (the "Effective
  Time").  At the Effective Time: (i) Merger Sub ceased to exist; (ii) IXYS USA,
  as the surviving corporation in the Merger, became a wholly-owned subsidiary of
  the Registrant; and (iii) subject to the provisions of the Agreement relating to
  the payment of cash in lieu of fractional shares, each share of IXYS USA Common
  Stock, par value $0.001 per share ("IXYS Common Stock"), and each share of IXYS
  Preferred Stock, par value $0.001 per share, outstanding immediately prior to
  the Effective Time (except for any such shares held by the Registrant as
  treasury stock and any such shares held by IXYS USA or any subsidiary of IXYS
  USA or the Registrant, which shares, if any, were canceled) was converted into
  the right to receive .057842 of a share of Common Stock, $0.01 par value per
  share, of the Registrant ("Registrant Common Stock"). Following the Merger, the
  Registrant changed its name to IXYS Corporation.
  
  In addition, pursuant to the Agreement, at the Effective Time, all rights with
  respect to IXYS Common Stock under IXYS USA stock options then outstanding, were
  converted into and became rights with respect to Registrant Common Stock, and
  the Registrant assumed each such outstanding IXYS USA stock option in accordance
  with the terms of the stock option plan under which it was issued and the stock
  option agreement by which it is evidenced. By virtue of the assumption by the
  Registrant of such IXYS USA stock options, from and after the Effective Time:
  (i) each IXYS USA stock option assumed by the Registrant may be exercised solely
  for Registrant Common Stock; (ii) the number of shares of Registrant Common
  Stock subject to each such IXYS USA stock option is equal to the number of
  shares of IXYS Common Stock subject to such IXYS USA stock option immediately
  prior to the Effective Time multiplied by .057842 (the exchange ratio in the
  Merger), rounded down to the nearest whole share (with cash, less the applicable
  exercise price, being payable for any fraction of a share); and (iii) the per
  share exercise price under each such Registrant stock option was adjusted by
  dividing the per share exercise price under such Registrant stock option by
   .057842 and rounding up to the nearest cent.
  
  The former stockholders of IXYS USA are receiving approximately 11,513,821
  shares of Registrant Common Stock pursuant to the Merger. In addition,
  approximately 274,914 shares of Registrant Common Stock may be issued in
  connection with the exercise of the IXYS USA stock options assumed by the
  Registrant.
  
  The Merger is intended to be a tax-free reorganization under the Internal
  Revenue Code of 1986, as amended, and is expected to be accounted for as a
  purchase.  
  
  Prior to the Merger, all outstanding shares of Preferred Stock of the Registrant
  were converted into Common Stock of the Registrant, and a reverse stock split of
  the Common Stock of the Registrant, pursuant to which each 15 shares were
  combined into one share, occurred.  Following such conversion and reverse stock
  split, and after giving effect to the Merger, as of September 
  
                                         3.
  30, 1998, there were approximately 11,955,670 shares of Common Stock of
  Registrant outstanding, options to acquire approximately 281,773 shares of
  Common Stock of Registrant outstanding and warrants to acquire approximately
  198,515 shares of Common Stock of Registrant outstanding. On such date, the
  weighted average exercise price per share of such options was approximately
  $5.94, the weighted average exercise price per share of the 195,881 warrants
  assumed under the Merger was approximately $1.42, and the weighted average
  exercise price per share of the 2,634 warrants which the Registrant had
  outstanding prior to the Merger was approximately $372.00.
  
  IXYS USA designs, develops and markets a broad spectrum of power semiconductors
  used primarily in controlling energy in motor drives, power conversion
  (including uninterruptible power supplies and switch mode power supplies) and
  medical devices.  IXYS USA's power semiconductors convert electricity at
  relatively high voltage and current levels to create efficient power as required
  by a specific application.  IXYS USA's target market includes segments of the
  power semiconductor market that require medium to high power semiconductors,
  with a particular emphasis on "higher power" semiconductors, which are
  semiconductors capable of processing greater than 500 watts of power.  The
  Registrant intends to continue to use the assets of IXYS USA for the purposes
  for which such assets were used prior to the Merger.
  
  See Item 1 for additional information.
  
  ITEM 7.  FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
  
          (a) Financial Statements of the Business Acquired
  
          The audited consolidated financial statements of IXYS Corporation as of
          March 31, 1997 and 1998 and for the three years in the period ended
          March 31, 1998 were included as part of the Registration Statement on
          Form S-4 (No. 33-57003) filed by the registrant with the Commission on
          June 6, 1998, and incorporated by reference herein. The unaudited
          condensed consolidated financial statements of IXYS Corporation as of
          June 30, 1998 and for the three month periods ended June 30, 1997 and
          1998 are included as Exhibit 99.1.
  
          (b) Pro Forma Financial Information
  
          The required pro forma financial information with respect to the
          acquired business referred to in Item 2 of this Report are included as
          Exhibit 99.1.
  
          (c) Exhibits
  
  EXHIBIT
    No.            DESCRIPTION
  -------          -----------
  
  2.1              Agreement and Plan of Merger and Reorganization dated as of
                   March 9, 1998, as amended, among IXYS, Merger Sub and
                   Paradigm./(1)/
  
                                         4.
  23.1             Consent of PricewaterhouseCoopers LLP, independent
                   accountants.
  
  99.1             Financial Statements.
  
  ____________________________
  
  /(1)/ Filed as an Annex to the Joint Proxy Statement/Prospectus forming part of
        the Registration Statement on Form S-4 (No. 333-57003) filed by the
        Registrant with the Commission on June 6, 1998, and incorporated by
        reference herein.
  
  Item 8.  Change in Fiscal Year.
  
  In connection with the Merger on September 23, 1998, the Registrant's fiscal
  year end will become March 31 of each calendar year. Because the transaction
  constituted a reverse acquisition under generally accepted accounting
  principles, no transition report will be filed with the Commission.
  
                                         5.
  SIGNATURES
  
  Pursuant to the requirements of the Securities Exchange Act of 1934, as amended,
  the registrant has duly caused this Report to be signed on its behalf by the
  undersigned hereunto duly authorized.
  
                                           IXYS CORPORATION
  
  Dated:  October 8, 1998                 By: /s/ Arnold P. Agbayani 
                                              ---------------------------------
                                              Arnold P. Agbayani
                                              Vice President of Finance and
                                              Administration and Chief
                                              Financial Officer
   
  
                                         6.
  Exhibit Index
  
      EXHIBIT
        NO.        DESCRIPTION
      -------      -----------
  
      2.1          Agreement and Plan of Merger and Reorganization dated as of
                   March 9, 1998, as amended, among IXYS, Merger Sub and
                   Paradigm./(1)/
  
      23.1         Consent of PricewaterhouseCoopers LLP, independent
                   accountants.
  
      99.1         Financial Statements.
  
  ____________________________
  
  /(1)/ Filed as an Annex to the Joint Proxy Statement/Prospectus forming part of
        the Registration Statement on Form S-4 (No. 333-57003) filed by Paradigm
        Technology, Inc. with the Commission on June 6, 1998, and incorporated by
        reference herein.